Últimas noticias sobre Lucid Diagnostics (NASDAQ:LUCD) Bolsa

Lucid Diagnostics

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Lucid Diagnostics Inc

Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) discussed its priorities for 2025 with Citi Research analyst Christopher Danely, which includes the company&#8217;s AI ambitions, solving CPU manufacturing issues, and the appointment of a new CEO.
What Happened: David Zinsner and Michelle Johnston Holthaus were named as the interim co-CEOs of Intel on Dec. 2, 2024, while the company searched for a permanent replacement. Former CEO Pat Gelsinger retired and stepped down from the board after over 40 years with the company.
Citi Research, in its research note dated Jan. 9, 2025, highlighted how it plans to work on the most pressing matters in the new year. This includes fixing the product roadmap, fixing CPU manufacturing, and establishing a meaningful foothold in the AI market.
The note also stated that the company will streamline its operations with a goal to gain market share in the CPU market in 2025. Citi reiterated its beliefs in Intel&#8217;s priorities.
Talking about the search for a new CEO, the research note added &#8220;We believe Intel could announce a new CEO within a couple of months and reiterate our Neutral rating.&#8221; The price target remained unchanged at $22 per share, assigned on Nov. 26, 2024.
See Also:<a href="https://www.benzinga.com/markets/equities/24/12/42378342/intel-stock-is-where-it-was-27-years-ago-how-the-worlds-leading-chipmaker-lost-the-plot-thrice"> Intel Stock Is Where It Was 27 Years Ago: How The World&#8217;s Leading Chipmaker Lost The Plot, Thrice</a> 
Why It Matters: Intel&#8217;s market capitalization has significantly lagged behind its competitors.
While Intel&#8217;s value stands at $85.7 billion, Qualcomm Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) market cap stands at $176.7 billion. Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), a key rival, boasts a market capitalization that is more than double of Intel&#8217;s at $197.7 billion.
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) towers above them all with a staggering market capitalization of $3.43 trillion, highlighting the significant gap in valuation within the semiconductor industry.
Additionally, Intel&#8217;s 13th and 14th-generation processors were plagued by persistent performance issues. In August 2024, the chip maker announced plans to cut 15% of its workforce, or about <a href="https://www.benzinga.com/government/24/08/40230583/intels-8-5b-government-windfall-fails-to-stop-15-000-layoffs-at-chipmaker">15,000 jobs</a>, despite receiving $8.5 billion in grants from the U.S. government.
Price Action: Intel&#8217;s stock was down 0.4% in premarket on Friday. The stock has declined by 42.99% over the last six months and by 58.12% over a year. Whereas, the Nasdaq 100 has outperformed with gains of 2.45% in the last six months and 26.13% over a year.
About 31 analysts <a href="https://www.benzinga.com/quote/INTC/analyst-ratings">tracked </a>by Benzinga have a consensus rating of &#8220;sell&#8221; with an average target price of $30.23 on Intel stock. BofA Securities, Northland Capital Markets, and Mizuho are among the three most recent analyst ratings, and their average price target stands at $24, implying a 20.85% upside.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/INTC/analyst-ratings"><img loading="lazy" decoding="async" width="942" height="355" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10045014/INTC-ANR.png" alt="" class="wp-image-727565" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10045014/INTC-ANR.png 942w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10045014/INTC-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10045014/INTC-ANR-768x289.png 768w" sizes="(max-width: 942px) 100vw, 942px" /></a></figure>
Read Next:
<ul>
<li><a href="https://benzinga.com/markets/equities/25/01/42906089/california-wildfires-ignite-concerns-for-insurance-stocks-here-are-some-insurance-etfs-which-could-be-impacted">California Wildfires Ignite Concerns For Insurance Stocks: Here Are Some Insurance ETFs Which Could Be Impacted </a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

News

Markets

Analyst Ratings

INTC

NVDA

QCOM

Intel Stock Has Fallen Over 58% In 1 Year, But Citi Maintains 'Neutral' Rating On Expected Replacement Of Pat Gelsinger In A 'Couple Of Months'

Needham analyst Matthew Sheerin initiates coverage on Evolent Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) with a Buy rating and announces Price Target of $15.

Price Target

Initiation

Needham Initiates Coverage On Evolent Health with Buy Rating, Announces Price Target of $15

On Thursday, January 9th, U.S. markets were closed in a mark of respect for the late former President Jimmy Carter.
U.S. Futures at 06:00 AM ET
<ul>
<li>Dow futures were down 0.10%, S&amp;P 500 futures fell 0.21% and Nasdaq 100 futures declined 0.23%.</li>
<li>U.S. stock futures dipped, weighed by Fed hawkishness, labor market strength, and inflation concerns. Markets await December payrolls for rate cues. Earnings season and rising oil prices add focus.</li>
</ul>
Asia Markets Today
<ul>
<li>On Friday, Japan&#8217;s Nikkei 225 closed lower by 1.04% at 39,208.50, led by losses in the Shipbuilding, Power, and Insurance sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.42%, ending the session at 8,294.10, led by losses in the Financials, Consumer Staples, and Healthcare sectors.</li>
<li>India&#8217;s Nifty 50 closed lower by 0.38% at 23,437.35, and the Nifty 500 slid 1.11%, closing at 21,801.10. The losses were caused by the Power, Real Estate, and Public Sector Undertakings sectors.</li>
<li>China&#8217;s Shanghai Composite was down 1.33% and closed at 3,168.52, while the Shenzhen CSI 300 declined 1.25% and finished the day at 3,732.48.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session lower by 0.92% at 19,064.29.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 was up 0.09%.</li>
<li>Germany&#8217;s DAX gained 0.20%.</li>
<li>France&#8217;s CAC rose 0.21%.</li>
<li>U.K.&#8217;s FTSE index 100 traded lower by 0.25%.</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 2.25% at $75.81/bbl, and Brent was up 2.46% at $78.83/bbl.</li>
<li>Oil prices rose for a third consecutive week amid supply concerns from sanctions on Russia and Iran, cold weather boosting fuel demand, and inflation worries despite a stronger U.S. dollar.</li>
<li>Natural Gas gained 4.16% to $3.852.</li>
<li>Gold was trading higher by 0.63% at $2,709.21, Silver was up 0.61% to $31.230, and Copper rose 0.69% to $4.3395.</li>
</ul>
Forex at 06:00 AM ET
<ul>
<li>The U.S. Dollar Index was down 0.01% to 109.17, USD/JPY rose 0.01% to 158.08, and USD/AUD gained 0.12% to 1.6159.</li>
<li>The U.S. dollar is on track for a sixth consecutive weekly gain, driven by elevated Treasury yields, inflation concerns, and expectations of strong nonfarm payrolls, signaling potential sustained higher rates.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Dollar Heads For 6th Weekly Gain; Asia Markets Decline, Europe Mixed - Global Markets Today While Us Slept

Needham analyst Matthew Sheerin initiates coverage on Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) with a Buy rating and announces Price Target of $25.

PRVA

Needham Initiates Coverage On Privia Health Gr with Buy Rating, Announces Price Target of $25

Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dip from its all-time high of $108,135 on Dec. 17 to its <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42899528/3-bearish-factors-that-could-drag-bitcoin-below-90000">current price around $93,100</a> has prompted questions about the market&#8217;s direction, the impact of government actions and what the future holds under the incoming Trump administration.
Benzinga spoke to several industry experts to take the temperature on Bitcoin&#8217;s near-term future,
<h2 class="wp-block-heading">Market Reversal: Temporary Dip Or A Vibe Shift?</h2>
The recent downturn has investors wondering if this is a minor correction or a sign of a more significant market shift. 
Patrick Liou, Principal of Institutional Sales at crypto exchange Gemini, points to stronger than expected U.S. economic data, especially in the labor market, which triggered a broad sell-off in risk assets, including Bitcoin.
Bradley Howell, Head of Linear Trading at Keyrock, agrees that the Federal Reserve&#8217;s Dec. 18 dot plot, indicating an expectation of only 50 basis points in rate cuts for 2025, impacted all markets.
Howell also noted that slower year-end markets and market participants taking time away from their screens contributed to the downturn, but suggested that the market should have fully priced this in by now.
Julian Beltran, CTO and co-founder of Stabolut, offers a more technical perspective, suggesting that the recent drop represents &#8220;natural profit-taking&#8221; after a period of consolidation near the $100,000 mark.
Beltran emphasizes that &#8220;key metrics remain bullish: ETF inflows continue steadily, institutional adoption is growing and market infrastructure is stronger than in previous cycles.&#8221;
Anastasija Plotnikova, CEO and Cofounder of Fideum, believes that the market has already absorbed the Fed&#8217;s December announcements, viewing the current situation as a &#8220;healthy correction&#8221; within the broader bull cycle. 
She notes the slower rate cut pace, concerns over sticky inflation and overall resilience in the U.S. economy as major sentiment driversL
&#8220;I do not believe there is a drastic vibe shift, this was expected conclusions from the Fed and market has priced it in,&#8221; she said.
Lee Bratcher, President of the Texas Blockchain Council (TBC), echoes this sentiment, describing the reversal as &#8220;a temporary dip in what has been an overall remarkable bull run for crypto.&#8221; 
Bratcher further points to &#8220;increased institutional interest&#8221; and a <a href="https://www.benzinga.com/25/01/42779917/trump-wont-announce-strategic-bitcoin-reserve-via-executive-order-says-analyst-he-would-likely-buy-btc-in-the-background">pro-crypto president</a> as drivers of long-term market strength: 
"With inflation fears remaining high, investors are likely to turn to safe-haven assets which can cause short-term draw downs for risk assets but those are typically short-term jitters that quickly get priced in."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42885028/gary-gensler-says-10000-15000-projects-wont-survive-crypto-market-is-wrapped-up-in-sentiment">Gary Gensler Says 10,000-15,000 Projects Won&#8217;t Survive, Crypto Market Is &#8216;Wrapped Up In Sentiment&#8217;</a>
<h2 class="wp-block-heading">Is The Government Dumping Its Bitcoin A Cause For Concern?</h2>
The announcement that the Department of Justice has <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42890745/us-government-silk-road-bitcoin-holdings-drop-to-0-amid-report-doj-approved-to-sell-6-5-billion-worth-of-crypto">been approved to sell $6.5 billion worth of Bitcoin</a> seized from the Silk Road has created further uncertainty.
Liou stated that this led to a further sell-off in crypto markets when the news broke, noting that the government is yet to proceed with the actual sales.
Howell, while acknowledging that it&#8217;s &#8220;not exactly bullish news,&#8221; puts the sale into context, highlighting the high daily trading volume of Bitcoin. 
"While the roughly 69,420 BTC that the DOJ plans on selling won&#8217;t go unnoticed, as long as they don&#8217;t try to sell it all on one day it should have limited impact on the market,&#8221; Howell noted.
Plotnikova sees a parallel between these sales and previous sales by <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41911120/the-german-government-sold-its-bitcoin-heres-how-much-it-missed-out-on">the German government</a>, emphasizing that &#8220;All that BTC was absorbed by the market and it did affect the price but only temporarily.&#8221;
Plotnikova adds that it was naive to expect that DOJ would allocate these BTC to a <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42531359/is-a-bitcoin-strategic-reserve-a-good-idea-expert-pushes-back-just-buy-btc-yourself">strategic Bitcoin reserve</a>.
She notes that if the sale is not complete until the new administration is sworn in, there might be some unexpected changes.
Bratcher believes that the sales represent a &#8220;moderate sell pressure&#8221; on Bitcoin but encourages the Trump administration to intervene. 
"Trump should put pressure on the Biden Administration not to sell the Bitcoin by making the general public aware of this pending transaction that would truly be the US shooting ourselves in the foot," he said.
<h2 class="wp-block-heading">Is The Inauguration Buy Or Sell The News?</h2>
Looking ahead to the <a href="https://www.benzinga.com/tech/25/01/42898021/google-donates-1-million-to-trump-inauguration-plans-youtube-livestream-pleased-to-support">upcoming presidential inauguration</a>, experts offer varied predictions.
Liou suggests the market is waiting to see the incoming administration's policy moves and that a "direction" could be found soon after the inauguration, depending on the policies and appointments.
Howell believes that Trump&#8217;s presidency is &#8220;fully priced in,&#8221; adding that if something were to prevent Trump from taking office, his VP, J.D. Vance, would likely be even more bullish for the market.
Beltran anticipates a potential &#8220;sell the news&#8221; scenario, where investors might take profits, despite the long-term crypto outlook being cautiously optimistic. 
According to Beltran, the market has likely already priced in <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42773793/trump-taking-office-could-spell-golden-crypto-era-industry-hopes">Trump&#8217;s pro-crypto policies</a>, making a significant pump on inauguration day is unlikely.
Plotnikova expects a period of "de-risking" from markets as investors "wait and see" what Trump will deliver. 
She also adds that the incoming administration is very bullish on crypto assets, preferring a predictable and friendly regulatory environment, and expects bullish sentiment to eventually prevail.
Bratcher sees pro-crypto sentiment, saying that, &#8220;If we see market structure and stablecoin legislation along with a U.S. Strategic Bitcoin Reserve, there is no reason why the bull market wouldn't extend throughout 2025.&#8221;
<h2 class="wp-block-heading">Was $108,000 The Top?</h2>
Asked for their opinion on whether the $108,000 price point was the peak for this cycle, experts m
Howell states a 1% chance, a sentiment echoed by Bratcher, who stated that there is a &#8220;99% chance&#8221; that this is not the high for the cycle.
Beltran admits that $108,000 represents a significant resistance level, but believes higher prices going forward are likely.
Plotnikova is very bullish, saying that $200,000 could be surpassed by the end of 2025. 
While the short-term outlook remains volatile, experts believe that underlying factors support continued growth in the long term. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42897245/bitcoin-silk-road-sales-would-affect-leverage-traders-more-than-holders-analyst-argues">Bitcoin Silk Road Sales Would Affect Leverage Traders More Than Holders, Analyst Argues</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

EXCLUSIVE: Answering Key Questions About Bitcoin's Future 10 Days Before The Inauguration

Needham analyst Matthew Sheerin reiterates Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) from Hold to Hold.

Reiteration

Needham Reiterates Hold on Agilon Healthto Hold

Global Blue Releases The Monthly Tax Free Shopping Business Update For December 2024: Says Issued Sales In Store Like-for-like Year-on-year Performance Reached +23% In December 2024

Deutsche Bank analyst Cave Montazeri upgrades Equitable Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) from Hold to Buy and raises the price target from $47 to $58.

Upgrades

Deutsche Bank Upgrades Equitable Hldgs to Buy, Raises Price Target to $58

Telsey Advisory Group analyst Dana Telsey maintains Honest Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) with a Market Perform and raises the price target from $6 to $7.

HNST

Telsey Advisory Group Maintains Market Perform on Honest Co, Raises Price Target to $7

Alchemab's technology platform uses patient samples from individuals with unusually slow rates of disease progression to identify antibodies associated with resilience.&nbsp;
&nbsp;

Biotech

Large Cap

Health Care

Contracts

General

On Thursday, Alchemab Therapeutics Entered A Collaboration With Eli Lilly To Discover, Develop, And Commercialize Up To Five Therapeutics For Amyotrophic Lateral Sclerosis; Alchemab Will Receive An Undisclosed Upfront Payment And Is Eligible To Receive Milestone Payments, Plus Royalties

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

Inspira Technologies Launches Preparation For Potential Production Ramp-up Of Its INSPIRA ART100 Device In Strategic Readiness Amid Recent Outbreak Of Human Metapneumovirus In China

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Vir Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) with a Buy and maintains $110 price target.

HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target

Deutsche Bank analyst Cave Montazeri upgrades Corebridge Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRBG#NYSE">CRBG</a>) from Hold to Buy and raises the price target from $33 to $40.

CRBG

Deutsche Bank Upgrades Corebridge Financial to Buy, Raises Price Target to $40

Telsey Advisory Group analyst Cristina Fernandez maintains Arhaus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARHS#NASDAQ">ARHS</a>) with a Outperform and maintains $11 price target.

ARHS

Telsey Advisory Group Maintains Outperform on Arhaus, Maintains $11 Price Target

HC Wainwright &amp; Co. analyst Oren Livnat reiterates Collegium Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLL#NASDAQ">COLL</a>) with a Buy and maintains $50 price target.

COLL

HC Wainwright & Co. Reiterates Buy on Collegium Pharmaceutical, Maintains $50 Price Target

<a target="_blank" href="https://www.benzinga.com/topic/semiconductors" rel="noreferrer noopener">Semiconductor chipmaker</a> Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) ended collaboration with Singapore&#8217;s PowerAIR after discovering a Taiwan Semiconductor chip&nbsp;in a Huawei Technologies artificial intelligence processor, SCMP <a target="_blank" href="https://www.scmp.com/tech/tech-war/article/3294199/tsmc-cuts-ties-singapore-firm-over-chip-found-huawei-processor-sources" rel="noreferrer noopener">reports</a>.
In 2024, the Taiwanese contract chipmaker <a target="_blank" href="https://www.benzinga.com/24/12/42644888/biden-administration-targets-chinese-firm-over-taiwan-semiconductor-chip-found-in-huawei-tech" rel="noreferrer noopener">suspended shipments to</a> China&#8217;s&nbsp;chip designing firm Sophgo after a chip it ordered from the Taiwanese chipmaker matched with one on Huawei&#8217;s Ascend 910B multi-chip system.
Washington imposed sanctions on Chinese smartphone giant Huawei in 2020, citing national security threats.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42882959/intel-partners-with-amazon-cloud-to-drive-next-gen-smart-vehicle-tech" rel="noreferrer noopener">Intel Partners with Amazon Cloud to Drive Next-Gen Smart Vehicle Tech, Wins Stellantis, Karma Auto As Clients</a>
The update coincides with reports indicating Nvidia and other chipmakers are susceptible to potential <a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/42897081/nvidia-and-ai-chip-stocks-brace-for-impact-as-biden-administration-considers-new-china-export-ban-report" rel="noreferrer noopener">U.S. AI chip sanctions</a> to China. Washington&#8217;s new curbs could restrict Nvidia&#8217;s AI chip shipments, with three-tier export rules favoring allies like Taiwan and barring Tier 3 nations like China.
Taiwan Semiconductor stock surged over 105% in the last 12 months, gaining prominence by manufacturing AI chips for Nvidia Corp GPUs and chips for Apple Inc smartphones.
Taiwan Semiconductor reported <a href="https://pr.tsmc.com/english/news/3198" target="_blank" rel="noreferrer noopener">consolidated revenue of</a> 2.89 trillion New Taiwan dollars between January and December 2024 (up by 33.9% year-on-year). It reported a <a href="https://pr.tsmc.com/english/news/3177" target="_blank" rel="noreferrer noopener">consolidated revenue of</a> 2.03 trillion New Taiwan dollars between January and September 2024. 
Therefore, it implies that the chipmaker reported a consolidated revenue of 868.46 billion New Taiwan dollars ($26.3 billion versus a consensus of $26.2 billion) for the December quarter versus $19.62 billion a year ago.
The company expects <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41373163/nvidia-supplier-tsmc-reports-q3-revenue-earnings-beat-amid-rising-demand-for-ai-chips" rel="noreferrer noopener">fourth-quarter revenue</a> of $26.1 billion &#8211; $26.9 billion.
Taiwan Semiconductor considered China the most significant revenue source after the U.S., as per the SCMP report. The chipmaker expected its China sales to grow by 26% in 2024 to $10.4 billion, accounting for 12% of its total revenue of $88.3 billion, SCMP cites Visible Alpha.
Investors can gain exposure to stocks of companies that manufacture semiconductors through the Invesco Semiconductors ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSI#NYSE">PSI</a>) and ProShares UltraShort Semiconductors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSG#NYSE">SSG</a>).
Price Action: TSM stock is up 1.34% at $209.89 premarket at last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42881889/uber-nvidia-partnership-to-unlock-value-by-leveraging-ai-to-advance-ridesharing-autonomous-tech-analyst" target="_blank" rel="noreferrer noopener">Uber, Nvidia Partnership To Unlock Value By Leveraging AI To Advance Ridesharing, Autonomous Tech: Analyst</a></li>
</ul>
Image via Shutterstock.

Equities

Government

Regulations

Tech

Media

AAPL

PowerShares Exchange-Traded Fund Trust Dynamic Semiconductor Portfolio

Taiwan Semiconductor Hits $26.3 Billion Q4 Revenue, Reportedly Ends PowerAIR Deal Over Huawei Chip Breach Amid US Sanctions

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is facing continued criticism as iPhone users report ongoing alarm issues, even after the release of iOS 18.
What Happened: Earlier this week, a Reddit user bryanlolwut highlighted the problem with a picture showing an alarm set for 10:30 AM that went off at 12:42 AM instead.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10051417/Screenshot-2025-01-10-at-3.44.04%E2%80%AFPM-1024x784.png" alt="" class="wp-image-727600" /><figcaption class="wp-element-caption">Source: Reddit</figcaption></figure>
See Also: <a href="https://www.benzinga.com/tech/25/01/42893958/after-apple-halts-hardware-subscription-plans-samsung-unveils-similar-strategy-for-ai-powered-galaxy-smartphones">After Apple Halts &#8216;Hardware&#8217; Subscription Plans, Samsung Unveils Similar Strategy For AI-Powered Galaxy Smartphones</a>
<a href="https://www.benzinga.com/news/24/05/38542253/iphone-alarms-on-mute-again-apple-acknowledges-issue-but-no-fix-timeline-yet">Apple acknowledged the alarm</a> reliability issues last year following a report by NBC&#8217;s Today show, promising a fix. However, users are still experiencing problems.
According to complaints, both iOS 17 and iOS 18 users are affected. Some have attempted to disable Apple&#8217;s Attention Awareness Features, which can lower alarm volume if the iPhone detects a face, but this has not resolved the issue for many.
Apple did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga's</a> request for comments.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: This isn&#8217;t the first instance of iPhone users reporting issues with their alarms not functioning properly. Back in 2017, a bug in iOS 11 was said to cause alarms to switch to silent mode.
Reports indicated that while the alarm interface would activate at the scheduled time, the ringer would fail to sound, leaving the iPhone effectively muted. Apple acknowledged the problem and later released a fix.
Similar issues surfaced in 2023 with iOS 17, where some users found their alarms failing to go off, resulting in oversleeping. At the time, several users noted that the problem seemed to be resolved following subsequent software updates.
Price Action: On Thursday, Apple&#8217;s stock saw a 0.20% increase, but during Friday&#8217;s pre-market session, the shares dipped by 0.11% to $242.44, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/01/42833727/dana-white-wanted-elon-musk-mark-zuckerberg-in-cage-fight-now-hes-on-metas-board-of-directors" target="_blank" rel="noreferrer noopener">Dana White Wanted Elon Musk, Mark Zuckerberg In Cage Fight, Now He&#8217;s On Meta&#8217;s Board Of Directors</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Apple's Alarm Issue Persists: iOS 18 Fails To Fix The Longstanding Problem Leaving Users Oversleeping

IMOS

ChipMOS' Q4 Revenues Totals $164.7M, Down 5.7% YoY Amid Macro Industry Pricing And Demand Headwind

Founded in 1983, aurenz maintains a leading position in the field of call accounting and in recent years in UC analytics. aurenz solutions provide essential added value for unified communication systems, easily and quickly integrating into every UC implementation. aurenz prides itself on delivering outstanding service to ensure seamless installations and integrations. Jürgen Dagutat, in his role as Managing Director, will continue to lead the aurenz team, ensuring continuity and further strengthening partnerships.
&nbsp;
UC analytics provides organizations with the data-driven insights necessary to optimize their communication strategies and with real-time feedback, to help identify and quickly resolve issues. UC analytics may also be used to enhance customer service interactions. By analyzing this data, companies can improve response times, identify common customer issues, and refine support processes to provide a better customer experience. In today's competitive environment, UC analytics helps to enrich operational efficiency and to achieve superior customer satisfaction.
&nbsp;
Ariel Glassner, Chief Executive Officer of MIND, commented: "This acquisition strengthens our position as a leading provider of UC analytics that can support businesses of all sizes. We believe that aurenz's solid reputation and proven expertise in the German market, its strong existing partnerships, and the great team of highly experienced professionals in the UC industry puts MIND in a good position for increased success in the European markets. Given our cash position and our experienced organization, we believe that we are well positioned and have the required resources to respond to market needs and continue with our dividend policy."
&nbsp;
Jürgen Dagutat, Managing Director of aurenz, commented: "The team at aurenz is genuinely enthusiastic about joining forces with a publicly listed company that offers global reach, robust financial strength, and a deep focus on our core markets. This merger creates substantial value for all partners and customers of both MIND and aurenz, as it combines the strengths of the two companies."
&nbsp;
MIND acquires aurenz for up to approximately $1.88 million in cash. The transaction is expected to be marginally accretive to our earnings per share, excluding acquisition-related items, in fiscal 2025 and thereafter. MIND's financial results will include the acquired company's results starting the first quarter of 2025.
&nbsp;
The acquisition is anticipated to be completed shortly, subject to customary closing requirements.
&nbsp;

MNDO

MIND C.T.I. Says It Has Signed A Definitive Agreement To Acquire Aurenz GmbH In Germany  For Up To Approximately $1.88M In Cash

ChipMOS Says It Expects 6.3% FY24 Revenue Growth, With A 5.4% YoY December 2024 Revenue Decline And A 5.7% YoY Q4 Revenue Decline

Lucid Diagnostics Inc. ( ($LUCD) ) has released its Q3 earnings. Here is a breakdown of the information Lucid Diagnostics Inc. presented to its inv...

Lucid Diagnostics Reports Q3 Revenue Growth and Strategic Expansion

BTIG analyst Mark Massaro reiterated a Buy rating on Lucid Diagnostics (LUCD – Research Report) yesterday and set a price target of $2.50. Mark Mas...

Lucid Diagnostics: Buy Rating Affirmed on Strong Revenue Growth and Future Expansion Potential

Kyle Mikson CFA, an analyst from Canaccord Genuity, maintained the Buy rating on Lucid Diagnostics (LUCD – Research Report). The associated price t...

Lucid Diagnostics: Strong Growth Potential Justifies Buy Rating

In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Lucid Diagnostics (LUCD – Research Report), with a pri...

Lucid Diagnostics: Strong Demand and Strategic Advancements Drive 'Buy' Rating

Lucid Diagnostics (LUCD), a subsidiary of PAVmed (PAVM), announced that it has submitted its complete clinical evidence package for its EsoGuard Es...

Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test

Lucid Diagnostics ( ($LUCD) ) has issued an announcement. Lucid Diagnostics Inc. recently secured $21.95 million through the sale of Senior Secured...

Lucid Diagnostics' Strategic Financial Maneuvering and Agreements

Lucid Diagnostics (LUCD) and subsidiary of PAVmed (PAVM), announced that the manuscript for its CLinical Utility of EsoGuard, or CLUE, study has be...

Lucid announces publication on EsoGuard in peer-reviewed journal Medicina

Lucid Diagnostics (LUCD), a subsidiary of PAVmed (PAVM), has entered into a strategic partnership with VITALExam, a comprehensive medical care prov...

Lucid Diagnostics partners for esophageal precancer detection for firefighters

Lucid Diagnostics receives 180-day extension by Nasdaq

Lucid Diagnostics (LUCD) announced that it had received written notification from the Listing Qualifications Department of the Nasdaq Stock Market ...

Lucid Diagnostics granted 180-day extension by Nasdaq to regain compliance

LUCD

PAVM

Press Releases

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Comments

Lucid Diagnostics

Noticias

Últimas noticias sobre Lucid Diagnostics (NASDAQ:LUCD) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL